Discontinuation and non-publication rates of U.S. clinical trials for the pharmacologic treatment of type 2 diabetes mellitus: A cross-sectional analysis

Research output: Contribution to journalLetterpeer-review

Original languageAmerican English
Article number101317
JournalDiabetes & Metabolism
Volume48
StateE-pub ahead of print - Mar 2022

Cite this